首站-论文投稿智能助手
典型文献
Harmine is an effective therapeutic small molecule for the treatment of cardiac hypertrophy
文献摘要:
Harmine is a β-carboline alkaloid isolated from Banisteria caapi and Peganum harmala L with various pharmacological activities,including antioxidant,anti-inflammatory,antitumor,anti-depressant,and anti-leishmanial capabilities.Nevertheless,the pharmacological effect of harmine on cardiomyocytes and heart muscle has not been reported.Here we found a protective effect of harmine on cardiac hypertrophy in spontaneously hypertensive rats in vivo.Further,harmine could inhibit the phenotypes of norepinephrine-induced hypertrophy in human embryonic stem cell-derived cardiomyocytes in vitro.It reduced the enlarged cell surface area,reversed the increased calcium handling and contractility,and downregulated expression of hypertrophy-related genes in norepinephrine-induced hypertrophy of human cardiomyocytes derived from embryonic stem cells.We further showed that one of the potential underlying mechanism by which harmine alleviates cardiac hypertrophy relied on inhibition of NF-KB phosphorylation and the stimulated inflammatory cytokines in pathological ventricular remodeling.Our data suggest that harmine is a promising therapeutic agent for cardiac hypertrophy independent of blood pressure modulation and could be a promising addition of current medications for cardiac hypertrophy.
文献关键词:
作者姓名:
Jie Huang;Yang Liu;Jia-xin Chen;Xin-ya Lu;Wen-jia Zhu;Le Qin;Zi-xuan Xun;Qiu-yi Zheng;Er-min Li;Ning Sun;Chen Xu;Hai-yan Chen
作者机构:
Department of Physiology and Pathophysiology,State Key Laboratory of Medical Neurobiology,School of Basic Medical Sciences,Fudan University,Shanghai 200032,China;Department of Echocardiography,Zhongshan Hospital,Fudan University,Shanghai 200032,China;Shanghai Key Lab of Birth Defect,Children's Hospital of Fudan University,Shanghai 201100,China;Research Center on Aging and Medicine,Fudan University,Shanghai 200032,China
引用格式:
[1]Jie Huang;Yang Liu;Jia-xin Chen;Xin-ya Lu;Wen-jia Zhu;Le Qin;Zi-xuan Xun;Qiu-yi Zheng;Er-min Li;Ning Sun;Chen Xu;Hai-yan Chen-.Harmine is an effective therapeutic small molecule for the treatment of cardiac hypertrophy)[J].中国药理学报(英文版),2022(01):50-63
A类:
Harmine,Banisteria,caapi,Peganum,leishmanial
B类:
effective,therapeutic,small,molecule,treatment,cardiac,hypertrophy,carboline,alkaloid,isolated,from,harmala,various,pharmacological,activities,including,antioxidant,inflammatory,antitumor,depressant,capabilities,Nevertheless,harmine,cardiomyocytes,heart,muscle,has,been,reported,Here,found,protective,spontaneously,hypertensive,rats,vivo,Further,could,phenotypes,norepinephrine,induced,human,embryonic,stem,derived,vitro,It,reduced,enlarged,surface,area,reversed,increased,calcium,handling,contractility,downregulated,expression,related,genes,cells,We,further,showed,that,one,potential,underlying,mechanism,by,which,alleviates,relied,inhibition,KB,phosphorylation,stimulated,cytokines,pathological,ventricular,remodeling,Our,data,suggest,promising,agent,independent,blood,pressure,modulation,addition,current,medications
AB值:
0.556705
相似文献
Spirulina platensis aqueous extracts ameliorate colonic mucosal damage and modulate gut microbiota disorder in mice with ulcerative colitis by inhibiting inflammation and oxidative stress
Jian WANG;Liqian SU;Lun ZHANG;Jiali ZENG;Qingru CHEN;Rui DENG;Ziyan WANG;Weidong KUANG;Xiaobao JIN;Shuiqing GUI;Yinghua XU;Xuemei LU-Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances,School of Life Science and Biopharmaceutics,Guangdong Pharmaceutical University,Guangzhou 510006,China;School of Pharmacy,Guangdong Pharmaceutical University,Guangzhou 510006,China;Intensive Care Unit,Shenzhen Second People's Hospital,the First Affiliated Hospital of Shenzhen University,Shenzhen 518031,China;Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products,National Institutes for Food and Drug Control,Beijing 102629,China
Propofol postconditioning ameliorates hypoxia/reoxygenation induced H9c2 cell apoptosis and autophagy via upregulating forkhead transcription factors under hyperglycemia
Rong‑Hui Han;He‑Meng Huang;Hong Han;Hao Chen;Fei Zeng;Xiang Xie;Dan‑Yong Liu;Yin Cai;Liang‑Qing Zhang;Xin Liu;Zheng‑Yuan Xia;Jing Tang-Department of Anesthesiology,Affiliated Hospital of Guangdong Medical University,57 South Renming Avenue Xiashan District,Zhanjiang 524000,Guangdong,China;Department of Emergency,Affiliated Hospital of Guangdong Medical University,Zhanjiang 524000,Guangdong,China;Department of Anesthesiology,the Eighth Affiliated Hospital,Sun Yat-Sen University,Guangzhou 518000,China;Department of Anesthesiology,Guangzhou First People's Hospital,the Second Affiliated Hospital of South China University of Technology,Guangzhou 510000,China;Department of Anesthesiology,the Second Affiliated Hospital and Yuying Children's Hospital,Wenzhou Medical University,Wenzhou 325000,Zhejiang,China;Department of Health Technology and Informatics,the Hong Kong Polytechnic University,Hung Hom 999077,Hong Kong SAR,China;State Key Laboratory of Pharmaceutical Biotechnology,Department of Medicine,the University of Hong Kong,Pok Fu Lam 999077,Hong Kong SAR,China
Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+T cell-mediated ferroptosis in castration-resistant prostate cancer
Xumin Zhou;Libin Zou;Hangyu Liao;Junqi Luo;Taowei Yang;Jun Wu;Wenbin Chen;Kaihui Wu;Shengren Cen;Daojun Lv;Fangpeng Shu;Yu Yang;Chun Li;Bingkun Li;Xiangming Mao-Department of Urology,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Second Department of Hepatobiliary Surgery,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Department of Urology,Minimally Invasive Surgery Center,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510120,China;Department of Urology,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China;Department of Urology,Peking University Shenzhen Hospital,Shenzhen 518036,China;Nursing Department,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China
Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK/NRF2 pathways
Xiang Wang;Xinxin Chen;Wenqian Zhou;Hongbo Men;Terigen Bao;Yike Sun;Quanwei Wang;Yi Tan;Bradley B.Keller;Qian Tong;Yang Zheng;Lu Cai-Pediatric Research Institute,Department of Pediatrics,University of Louisville School of Medicine,Louisville,KY 40202,USA;Department of Cardiovascular Disease,the First Hospital of Jilin University,Changchun 130021,China;Department of Burn Surgery,First Hospital of Jilin University,Jilin University,Changchun 130021,China;Department of Pharmacology and Toxicology,University of Louisville School of Medicine,Louisville,KY 40202,USA;Pediatric Heart Research Program,Cardiovascular Innovation Institute,University of Louisville School of Medicine,Louisville,KY 40202,USA;Cincinnati Children's Heart Institute,Greater Louisville and Western Kentucky Practice,Louisville,KY 40202,USA
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
Abivertinib inhibits megakaryocyte differentiation and platelet biogenesis
Jiansong Huang;Xin Huang;Yang Li;Xia Li;Jinghan Wang;Fenglin Li;Xiao Yan;Huanping Wang;Yungui Wang;Xiangjie Lin;Jifang Tu;Daqiang He;Wenle Ye;Min Yang;Jie Jin-Department of Hematology,Key Laboratory of Hematologic Malignancies,Diagnosis and Treatment,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Institute of Hematology,Zhejiang University School of Medicine,Hangzhou 310003,China;Department of Obstetrics,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Department of Hematology,Qingdao Municipal Hospital,Qingdao 266000,China;Department of Laboratory Medicine,Affiliated Hangzhou First People's Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Cancer Center Zhejiang University,Hangzhou 310058,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。